Cc1cc(C(=O)N2CCC2(C)C(=O)NS(=O)(=O)c2ccc(F)cc2F)nn1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?